About Cell Engineering & Gene Therapy Tools
The Cell Engineering & Gene Therapy Tools category is part of the Synthetic Biology market map, tracking 15 companies building in this segment. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. Curated by Hartmann Capital's venture research team.
Companies in Cell Engineering & Gene Therapy Tools
- Editas Medicine — Public, $741M
- Intellia Therapeutics — Public, $889M
- Beam Therapeutics — Public, $665M
- Prime Medicine — Public, $315M
- Caribou Biosciences — Public, $318M
- Verve Therapeutics — Acquired, $419M
- Scribe Therapeutics — Series B, $120M
- Arbor Biotechnologies — Series C, $134M
- Dyno Therapeutics — Series A, $100M
- Spotlight Therapeutics — Series A, $30M
- Precigen — Public, $450M
- Synlogic — Public, $326M
- Poseida Therapeutics — Acquired, $461M
- Umoja Biopharma — Series B, $210M
- Tierra Biosciences — Series A, $25M
Frequently Asked Questions
- What companies are in the Cell Engineering & Gene Therapy Tools category?
- The Cell Engineering & Gene Therapy Tools category includes 15 companies: Editas Medicine, Intellia Therapeutics, Beam Therapeutics, Prime Medicine, Caribou Biosciences, Verve Therapeutics, Scribe Therapeutics, Arbor Biotechnologies, Dyno Therapeutics, Spotlight Therapeutics, Precigen, Synlogic, Poseida Therapeutics, Umoja Biopharma, Tierra Biosciences. This is part of the Synthetic Biology market map maintained by Hartmann Capital.
- How many Cell Engineering & Gene Therapy Tools startups are tracked?
- Hartmann Capital tracks 15 companies in the Cell Engineering & Gene Therapy Tools segment of the Synthetic Biology market map.
- What are the best funded Cell Engineering & Gene Therapy Tools companies?
- Top funded companies in Cell Engineering & Gene Therapy Tools include Intellia Therapeutics ($889M), Editas Medicine ($741M), Beam Therapeutics ($665M), Poseida Therapeutics ($461M), Precigen ($450M). Browse the full list in the Synthetic Biology market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.